Suchergebnisse - "Schwarze, Julia Katharina"

PubPharm (28)

1

Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition

enthalten in: Journal of neuro-oncology | 2024

von Geens, W. | Vanlaer, N. | Nijland, L. | +6

2

Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma

enthalten in: Journal for immunotherapy of cancer | 2024

von Tijtgat, J. | Geeraerts, X. | Boisson, A. | +10

3

Current "state of the art" on dendritic cell-based cancer vaccines in melanoma

enthalten in: Current opinion in oncology | 2023

von Schwarze, J. | Geeraerts, X. | Tuyaerts, S. | +1

4

Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients : a phase I clinical trial

enthalten in: Journal for immunotherapy of cancer | 2022

von Schwarze, J. | Tijtgat, J. | Awada, G. | +8

5

A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors

enthalten in: Melanoma research | 2022

von Awada, G. | Schwarze, J. | Tijtgat, J. | +3

6

Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases : A Sequential Dual Cohort Phase II Clinical Trial

enthalten in: Cancers | 2022

von Schwarze, J. | Garaud, S. | Jansen, Y. | +8

7

C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting

enthalten in: Melanoma research | 2021

von Lauwyck, J. | Beckwée, A. | Santens, A. | +5

8

Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma : a phase I clinical trial

enthalten in: Journal for immunotherapy of cancer | 2021

von Duerinck, J. | Schwarze, J. | Awada, G. | +18

9

Sarcoid-like reaction in a BRAF V600E-mutated metastatic melanoma patient during treatment with BRAF/MEK-targeted therapy

enthalten in: Melanoma research | 2021

von Tijtgat, J. | Schwarze, J. | Awada, G. | +2

10

A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRASQ61R/K/L Mutant Melanoma (TraMel-WT)

enthalten in: Cancers | 2021

von Awada, G. | Schwarze, J. | Tijtgat, J. | +3